{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:06:13Z","timestamp":1768475173708,"version":"3.49.0"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,16]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Burkholderia pseudomallei is the causative agent of melioidosis. Historically believed to be a relatively rare human disease in tropical countries, a recent study estimated that, worldwide, there are approximately 165 000 human melioidosis cases per year, more than half of whom die. The bacterium is inherently resistant to many antibiotics and treatment of the disease is often protracted and ineffective. There is no licensed vaccine against melioidosis, but a vaccine is predicted to be of value if used in high-risk populations. There has been progress over the last decade in the pursuit of an effective vaccine against melioidosis. Animal models of disease including mouse and non-human primates have been developed, and these models show that antibody responses play a key role in protection against melioidosis. Surprisingly, although B. pseudomallei is an intracellular pathogen there is limited evidence that CD8+ T cells play a role in protection. It is evident that a multi-component vaccine, incorporating one or more protective antigens, will probably be essential for protection because of the pathogen's sophisticated virulence mechanisms as well as strain heterogeneity. Multi-component vaccines in development include glycoconjugates, multivalent subunit preparations, outer membrane vesicles and other nano\/microparticle platforms and live-attenuated or inactivated bacteria. A consistent finding with vaccine candidates tested in mice is the ability to induce sterilizing immunity at low challenge doses and extended time to death at higher challenge doses. Further research to identify ways of eliciting more potent immune responses might provide a path for licensing an effective vaccine.<\/jats:p>","DOI":"10.1111\/cei.13286","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T02:34:45Z","timestamp":1554777285000},"page":"178-188","source":"Crossref","is-referenced-by-count":32,"title":["Novel multi-component vaccine approaches for <i>Burkholderia pseudomallei<\/i>"],"prefix":"10.1093","volume":"196","author":[{"given":"L","family":"Morici","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A G","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R W","family":"Titball","sequence":"additional","affiliation":[{"name":"College of Life and Environmental Science, University of Exeter, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"2022011423124372100_cei13286-bib-0001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/bmb\/ldr007","article-title":"Melioidosis: a clinical overview","volume":"99","author":"Limmathurotsakul","year":"2011","journal-title":"Br Med Bull"},{"key":"2022011423124372100_cei13286-bib-0002","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.1038\/nrdp.2017.107","article-title":"Melioidosis","volume":"4","author":"Wiersinga","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2022011423124372100_cei13286-bib-0003","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/CMR.4.1.52","article-title":"Melioidosis \u2013 the tip of the iceberg","volume":"4","author":"Dance","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"2022011423124372100_cei13286-bib-0004","first-page":"249","article-title":"Melioidosis, the great mimicker: a report of 10 cases from Malaysia","volume":"91","author":"Yee","year":"1988","journal-title":"J Trop Med Hyg"},{"key":"2022011423124372100_cei13286-bib-0005","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMra1204699","article-title":"Melioidosis","volume":"367","author":"Wiersinga","year":"2012","journal-title":"N Engl J Med"},{"key":"2022011423124372100_cei13286-bib-0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/trstmh\/try124","article-title":"The double burden of diabetes and global infection in low and middle-income countries","volume":"113","author":"Dunachie","year":"2018","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022011423124372100_cei13286-bib-0007","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1099\/jmm.0.47043-0","article-title":"Polysaccharides and virulence of Burkholderia pseudomallei","volume":"56","author":"Sarkar-Tyson","year":"2007","journal-title":"J Med Microbiol"},{"key":"2022011423124372100_cei13286-bib-0008","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro1385","article-title":"Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei","volume":"4","author":"Wiersinga","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"2022011423124372100_cei13286-bib-0009","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1586\/14787210.2014.970634","article-title":"Melioidosis: molecular aspects of pathogenesis","volume":"12","author":"Stone","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2022011423124372100_cei13286-bib-0010","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2217\/fmb.12.116","article-title":"Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis","volume":"7","author":"Schweizer","year":"2012","journal-title":"Future Microbiol"},{"key":"2022011423124372100_cei13286-bib-0011","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis","volume":"43","author":"Dance","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"2022011423124372100_cei13286-bib-0012","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/14787210.4.3.445","article-title":"Management of melioidosis","volume":"4","author":"Wuthiekanun","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2022011423124372100_cei13286-bib-0013","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-3156.2004.01328.x","article-title":"Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia","volume":"9","author":"Currie","year":"2004","journal-title":"Trop Med Int Health"},{"key":"2022011423124372100_cei13286-bib-0014","doi-asserted-by":"crossref","first-page":"15008","DOI":"10.1038\/nmicrobiol.2015.8","article-title":"Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis","volume":"1","author":"Limmathurotsakul","year":"2016","journal-title":"Nat Microbiol"},{"key":"2022011423124372100_cei13286-bib-0015","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3201\/eid2307.161978","article-title":"Phylogeography of Burkholderia pseudomallei isolates, western hemisphere","volume":"23","author":"Gee","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2022011423124372100_cei13286-bib-0016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/tropicalmed3010013","article-title":"Global burden and challenges of melioidosis","volume":"3","author":"Dance","year":"2018","journal-title":"Trop Med Infect Dis"},{"key":"2022011423124372100_cei13286-bib-0017","doi-asserted-by":"crossref","first-page":"16263","DOI":"10.1038\/nmicrobiol.2016.263","article-title":"Global and regional dissemination and evolution of Burkholderia pseudomallei","volume":"2","author":"Chewapreecha","year":"2017","journal-title":"Nat Microbiol"},{"key":"2022011423124372100_cei13286-bib-0018","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4269\/ajtmh.18-0418","article-title":"Melioidosis is in the Americas: a call to action for diagnosing and treating the disease","volume":"99","author":"Torres","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2022011423124372100_cei13286-bib-0019","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fmicb.2010.00141","article-title":"Evaluation of surrogate animal models of melioidosis","volume":"1","author":"Warawa","year":"2010","journal-title":"Front Microbiol"},{"key":"2022011423124372100_cei13286-bib-0020","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.clinthera.2010.07.020","article-title":"Progress toward development of vaccines against melioidosis: a review","volume":"32","author":"Sarkar-Tyson","year":"2010","journal-title":"Clin Ther"},{"key":"2022011423124372100_cei13286-bib-0021","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1016\/j.vaccine.2017.03.022","article-title":"Burkholderia pseudomallei and Burkholderia mallei vaccines: are we close to clinical trials?","volume":"35","author":"Titball","year":"2017","journal-title":"Vaccine"},{"key":"2022011423124372100_cei13286-bib-0022","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S0035-9203(08)70026-9","article-title":"Burkholderia pseudomallei: animal models of infection","volume":"102","author":"Titball","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022011423124372100_cei13286-bib-0023","doi-asserted-by":"crossref","first-page":"e0172627","DOI":"10.1371\/journal.pone.0172627","article-title":"Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB\/c and C57BL\/6 mice","volume":"12","author":"Bearss","year":"2017","journal-title":"PLOS ONE"},{"key":"2022011423124372100_cei13286-bib-0024","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","article-title":"Innate immune response in Th1- and Th2-dominant mouse strains","volume":"22","author":"Watanabe","year":"2004","journal-title":"Shock"},{"key":"2022011423124372100_cei13286-bib-0025","doi-asserted-by":"crossref","DOI":"10.3201\/eid2106.141480","article-title":"Consensus on the development of vaccines against naturally acquired melioidosis","volume":"21","author":"Limmathurotsakul","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2022011423124372100_cei13286-bib-0026","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajpath.2011.03.031","article-title":"Low-dose exposure of C57BL\/6 mice to Burkholderia pseudomallei mimics chronic human melioidosis","volume":"179","author":"Conejero","year":"2011","journal-title":"Am J Pathol"},{"key":"2022011423124372100_cei13286-bib-0027","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.provac.2014.07.007","article-title":"Evaluation of a Burkholderia pseudomallei outer membrane vesicle vaccine in nonhuman primates","volume":"8","author":"Petersen","year":"2014","journal-title":"Procedia Vaccinol"},{"key":"2022011423124372100_cei13286-bib-0028","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.3390\/vaccines5040049","article-title":"Burkholderia pseudomallei outer membrane vesicle vaccine provides cross protection against inhalational glanders in mice and non-human primates","volume":"5","author":"Baker","year":"2017","journal-title":"Vaccines"},{"key":"2022011423124372100_cei13286-bib-0029","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.vaccine.2014.11.057","article-title":"Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine","volume":"33","author":"Torres","year":"2015","journal-title":"Vaccine"},{"key":"2022011423124372100_cei13286-bib-0030","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2613.2011.00791.x","article-title":"Development of an acute model of inhalational melioidosis in the common marmoset (Callithrix jacchus)","volume":"92","author":"Nelson","year":"2011","journal-title":"Int J Exp Pathol"},{"key":"2022011423124372100_cei13286-bib-0031","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/iep.12105","article-title":"Comparative experimental subcutaneous glanders and melioidosis in the common marmoset (Callithrix jacchus)","volume":"95","author":"Nelson","year":"2014","journal-title":"Int J Exp Pathol"},{"key":"2022011423124372100_cei13286-bib-0032","doi-asserted-by":"crossref","first-page":"e1488","DOI":"10.1371\/journal.pntd.0001488","article-title":"Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes","volume":"6","author":"Peacock","year":"2012","journal-title":"PLOS Negl Trop Dis"},{"key":"2022011423124372100_cei13286-bib-0033","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/febs.13223","article-title":"From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK","volume":"282","author":"Gourlay","year":"2015","journal-title":"FEBS J"},{"key":"2022011423124372100_cei13286-bib-0034","doi-asserted-by":"crossref","first-page":"e0198906","DOI":"10.1371\/journal.pone.0198906","article-title":"Immune response to recombinant Burkholderia pseudomallei FliC","volume":"13","author":"Koosakulnirand","year":"2018","journal-title":"PLOS ONE"},{"key":"2022011423124372100_cei13286-bib-0035","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.vaccine.2006.12.006","article-title":"The identification of surface proteins of Burkholderia pseudomallei","volume":"25","author":"Harding","year":"2007","journal-title":"Vaccine"},{"key":"2022011423124372100_cei13286-bib-0036","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/infdis\/jiq142","article-title":"Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis","volume":"203","author":"Suwannasaen","year":"2011","journal-title":"J Infect Dis"},{"key":"2022011423124372100_cei13286-bib-0037","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/eji.201040881","article-title":"CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis","volume":"41","author":"Chu","year":"2011","journal-title":"Eur J Immunol"},{"key":"2022011423124372100_cei13286-bib-0038","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1371\/journal.pntd.0000407","article-title":"Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei","volume":"3","author":"Tippayawat","year":"2009","journal-title":"PLOS Negl Trop Dis"},{"key":"2022011423124372100_cei13286-bib-0039","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/IAI.00803-10","article-title":"Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro","volume":"79","author":"Tippayawat","year":"2011","journal-title":"Infect Immun"},{"key":"2022011423124372100_cei13286-bib-0040","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1073\/pnas.0812080106","article-title":"A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens","volume":"106","author":"Felgner","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011423124372100_cei13286-bib-0041","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.4049\/jimmunol.1402273","article-title":"CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis","volume":"193","author":"Musson","year":"2014","journal-title":"J Immunol"},{"key":"2022011423124372100_cei13286-bib-0042","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.4049\/jimmunol.1402862","article-title":"T Cell immunity to the alkyl hydroperoxide reductase of Burkholderia pseudomallei: a correlate of disease outcome in acute melioidosis","volume":"194","author":"Reynolds","year":"2015","journal-title":"J Immunol"},{"key":"2022011423124372100_cei13286-bib-0043","doi-asserted-by":"crossref","first-page":"12143","DOI":"10.1038\/s41598-017-12331-5","article-title":"Infection with Burkholderia pseudomallei \u2013 immune correlates of survival in acute melioidosis","volume":"7","author":"Dunachie","year":"2017","journal-title":"Sci Rep"},{"key":"2022011423124372100_cei13286-bib-0044","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1128\/IAI.01847-14","article-title":"Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis","volume":"82","author":"Scott","year":"2014","journal-title":"Infect Immun"},{"key":"2022011423124372100_cei13286-bib-0045","first-page":"108","article-title":"Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders","volume":"2","author":"Burtnick","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"2022011423124372100_cei13286-bib-0046","first-page":"IAI.00724","article-title":"Development of subunit vaccines that provide high level protection and sterilizing immunity against acute inhalational melioidosis","volume":"pii","author":"Burtnick","year":"2017","journal-title":"Infect Immun"},{"key":"2022011423124372100_cei13286-bib-0047","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/acs.bioconjchem.5b00525","article-title":"Protection against experimental melioidosis with a synthetic manno-heptopyranose hexasaccharide glycoconjugate","volume":"27","author":"Scott","year":"2016","journal-title":"Bioconjug Chem"},{"key":"2022011423124372100_cei13286-bib-0048","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fmicb.2014.00381","article-title":"Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery","volume":"5","author":"Garcia-Quintanilla","year":"2014","journal-title":"Front Microbiol"},{"key":"2022011423124372100_cei13286-bib-0049","doi-asserted-by":"crossref","first-page":"392170","DOI":"10.1155\/2014\/392170","article-title":"Protection against experimental melioidosis following immunisation with a lipopolysaccharide\u2013protein conjugate","volume":"2014","author":"Scott","year":"2014","journal-title":"J Immunol Res"},{"key":"2022011423124372100_cei13286-bib-0050","first-page":"CVI.00206","article-title":"The use of reverse vaccinology in the design and construction of nano\u2013glycoconjugate vaccines against Burkholderia pseudomallei","volume":"pii","author":"Muruato","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"2022011423124372100_cei13286-bib-0051","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.vaccine.2016.03.088","article-title":"Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis","volume":"34","author":"Casey","year":"2016","journal-title":"Vaccine"},{"key":"2022011423124372100_cei13286-bib-0052","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fcimb.2012.00085","article-title":"Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice","volume":"2","author":"Chin","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"2022011423124372100_cei13286-bib-0053","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/IAI.01218-10","article-title":"The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei","volume":"79","author":"Burtnick","year":"2011","journal-title":"Infect Immun"},{"key":"2022011423124372100_cei13286-bib-0054","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1016\/j.vaccine.2010.05.022","article-title":"Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice","volume":"28","author":"Su","year":"2010","journal-title":"Vaccine"},{"key":"2022011423124372100_cei13286-bib-0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.provac.2010.03.013","article-title":"Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge","volume":"2","author":"Whitlock","year":"2010","journal-title":"Procedia Vaccinol"},{"key":"2022011423124372100_cei13286-bib-0056","doi-asserted-by":"crossref","first-page":"e6496","DOI":"10.1371\/journal.pone.0006496","article-title":"Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets","volume":"4","author":"Hara","year":"2009","journal-title":"PLOS ONE"},{"key":"2022011423124372100_cei13286-bib-0057","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.vaccine.2016.02.038","article-title":"Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease","volume":"34","author":"Champion","year":"2016","journal-title":"Vaccine"},{"key":"2022011423124372100_cei13286-bib-0058","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1016\/j.vaccine.2011.08.058","article-title":"A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection","volume":"29","author":"Nieves","year":"2011","journal-title":"Vaccine"},{"key":"2022011423124372100_cei13286-bib-0059","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CVI.00119-14","article-title":"A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis","volume":"21","author":"Nieves","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"2022011423124372100_cei13286-bib-0060","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ijpharm.2015.09.059","article-title":"Evaluation of a biodegradable microparticulate polymer as a carrier for Burkholderia pseudomallei subunit vaccines in a mouse model of melioidosis","volume":"495","author":"Schully","year":"2015","journal-title":"Int J Pharm"},{"key":"2022011423124372100_cei13286-bib-0061","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1016\/j.vaccine.2011.05.009","article-title":"Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity","volume":"29","author":"Henderson","year":"2011","journal-title":"Vaccine"},{"key":"2022011423124372100_cei13286-bib-0062","first-page":"123","article-title":"Construction and characterization of an unmarked aroC deletion mutant of Burkholderia pseudomallei strain A2","volume":"40","author":"Srilunchang","year":"2009","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2022011423124372100_cei13286-bib-0063","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/IAI.01313-09","article-title":"A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists","volume":"78","author":"Propst","year":"2010","journal-title":"Infect Immun"},{"key":"2022011423124372100_cei13286-bib-0064","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1128\/IAI.00915-13","article-title":"Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine","volume":"81","author":"Silva","year":"2013","journal-title":"Infect Immun"},{"key":"2022011423124372100_cei13286-bib-0065","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1128\/IAI.00178-12","article-title":"Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity","volume":"80","author":"Muller","year":"2012","journal-title":"Infect Immun"},{"key":"2022011423124372100_cei13286-bib-0066","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1128\/IAI.05044-11","article-title":"The Burkholderia pseudomallei Deltaasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice","volume":"79","author":"Norris","year":"2011","journal-title":"Infect Immun"},{"key":"2022011423124372100_cei13286-bib-0067","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00570-18","article-title":"Burkholderia pseudomallei \u0394tonB 1 \u0394hcp1 live attenuated vaccine strain elicits full protective immunity against aerosolized melioidosis infection","author":"Khakhum","year":"2019","journal-title":"mSphere"},{"key":"2022011423124372100_cei13286-bib-0068","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1128\/CVI.00113-13","article-title":"Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule","volume":"20","author":"Scott","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"2022011423124372100_cei13286-bib-0069","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1128\/JCM.01585-06","article-title":"Pneumonia and septicemia caused by Burkholderia thailandensis in the United States","volume":"44","author":"Glass","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2022011423124372100_cei13286-bib-0070","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3201\/eid2411.180821","article-title":"Burkholderia thailandensis isolated from infected wound, Arkansas, USA","volume":"24","author":"Gee","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2022011423124372100_cei13286-bib-0071","volume-title":"Vaccines","author":"Plotkin","year":"2008","edition":"5th edn"},{"key":"2022011423124372100_cei13286-bib-0072","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1128\/iai.65.9.3648-3653.1997","article-title":"Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies","volume":"65","author":"Ho","year":"1997","journal-title":"Infect Immun"},{"key":"2022011423124372100_cei13286-bib-0073","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1086\/520441","article-title":"Antilipopolysaccharide II: an antibody protective against fatal melioidosis","volume":"29","author":"Charuchaimontri","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2022011423124372100_cei13286-bib-0074","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/imm.12709","article-title":"Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins","volume":"151","author":"Nithichanon","year":"2017","journal-title":"Immunology"},{"key":"2022011423124372100_cei13286-bib-0075","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1099\/jmm.0.45766-0","article-title":"Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis","volume":"53","author":"Nelson","year":"2004","journal-title":"J Med Microbiol"},{"key":"2022011423124372100_cei13286-bib-0076","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/iai.64.7.2824-2828.1996","article-title":"Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide\u2013flagellin protein conjugates","volume":"64","author":"Brett","year":"1996","journal-title":"Infect Immun"},{"key":"2022011423124372100_cei13286-bib-0077","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1099\/0022-1317-51-12-1055","article-title":"Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins","volume":"51","author":"Jones","year":"2002","journal-title":"J Med Microbiol"},{"key":"2022011423124372100_cei13286-bib-0078","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.vaccine.2005.08.069","article-title":"Immunogenicity and anti-Burkholderia pseudomallei activity in Balb\/c mice immunized with plasmid DNA encoding flagellin","volume":"24","author":"Chen","year":"2006","journal-title":"Vaccine"},{"key":"2022011423124372100_cei13286-bib-0079","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1086\/508217","article-title":"A live experimental vaccine against Burkholderia pseudomallei elicits CD4(+) T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins","volume":"194","author":"Haque","year":"2006","journal-title":"J Infect Dis"},{"key":"2022011423124372100_cei13286-bib-0080","doi-asserted-by":"crossref","first-page":"e0004152","DOI":"10.1371\/journal.pntd.0004152","article-title":"T-cell responses are associated with survival in acute melioidosis patients","volume":"9","author":"Jenjaroen","year":"2015","journal-title":"PLOS Negl Trop Dis"},{"key":"2022011423124372100_cei13286-bib-0081","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7883\/yoken1952.45.247","article-title":"A preliminary survey for human immunodeficient virus (HIV) infections in tuberculosis and melioidosis patients in Ubon Ratchathani, Thailand","volume":"45","author":"Kanai","year":"1992","journal-title":"Jpn J Med Sci Biol"},{"key":"2022011423124372100_cei13286-bib-0082","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1389203043379774","article-title":"Proteasome function in antigen presentation: immunoproteasome complexes, peptide production, and interactions with viral proteins","volume":"5","author":"Rivett","year":"2004","journal-title":"Curr Protein Pept Sci"},{"key":"2022011423124372100_cei13286-bib-0083","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nri2575","article-title":"MHC class I antigen presentation: learning from viral evasion strategies","volume":"9","author":"Hansen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2022011423124372100_cei13286-bib-0084","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.micpath.2017.03.015","article-title":"A proteasome inhibitor produced by Burkholderia pseudomallei modulates intracellular growth","volume":"107","author":"Wagley","year":"2017","journal-title":"Microb Pathog"},{"key":"2022011423124372100_cei13286-bib-0085","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1073\/pnas.1311725110","article-title":"Burkholderia pseudomallei suppresses Caenorhabditis elegans immunity by specific degradation of a GATA transcription factor","volume":"110","author":"Lee","year":"2013","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13286","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13286","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/196\/2\/178\/42197338\/cei13286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/196\/2\/178\/42197338\/cei13286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T23:16:07Z","timestamp":1642202167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/196\/2\/178\/6421397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":85,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,4,8]]},"published-print":{"date-parts":[[2019,4,16]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13286","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2019,4,8]]}}}